Science Market Update

UC San Diego Receives Two, $2M Research Grants from CIRM

Posted by Rebecca Partridge on Mon, Feb 20, 2017

 

The California Institute for Regenerative Medicine (CIRM) awarded two scientists at UC San Diego $2 million each for their innovative research. The first award went to Alysson R. Muotri, PhD, professor in the UC San Diego School of Medicine departments of Pediatrics and Cellular and Molecular Medicine. The funding will support studies of new treatments for Zika. The second award went to Dan Kaufman, MD, PhD, professor of medicine in the Division of Regenerative Medicine. This funding will support the creation an “off-the-shelf immunotherapy” using NK cells to treat refractory or resistant tumors, such as ovarian cancer.

Read More

Tags: Bioresearch funding, Cancer Treatment, Cancer, Biotechnology Vendor Fair, UCSD, UC San Diego, CIRM, research grants, zika, Biotechnology trade show

Breast Cancer Research Breakthrough at UI Urbana-Champaign

Posted by Rebecca Partridge on Wed, Oct 12, 2016

According to the American Cancer Society, 1 in 8 American women will develop invasive breast cancer in their lifetime, and each year over 40,000 women die from it. However, thanks to research conducted at the University of Illinois Urbana-Champaign, the number of deaths due to breast cancer may soon be significantly reduced. 

Read More

Tags: breast cancer research, University of Illinois Urbana-Champaign, cancer research, Cancer Treatment, Cancer, UI Urbana, Midwest Region, UIUC, cancer therapy

$29M Core Grant Awarded to Alabama for Cancer Research Center

Posted by Rebecca Partridge on Wed, Jun 29, 2016

(Image courtesy of Wikimedia commons)

University of Alabama at Birmingham received a $29 million grant from the National Cancer Institute. This five year core grant will support six research programs at the UAB Comprehensive Cancer Center. The renewal of the Cancer Center Support Grant, the most prestigious federal grant that a cancer research and treatment program can earn, also extends UAB’s elite “comprehensive” designation. According to the UAB News website this designation is awarded for scientific excellence and the ability to integrate diverse research approaches in the fight against cancer.

Read More

Tags: Bioresearch funding, cancer research, Alabama, University of Alabama, Cancer Treatment, Cancer, University of Alabama Birmingham, UAlab, UAB, University of Alabama at Birmingham, Cancer Center, cancer researchers, fight cancer, 2016, cancer reserach, Bioresearch Grant, Comprehensive Cancer Center

$13.7M Awarded to St. Louis Researchers to Develop Multiple Myeloma Treatments

Posted by Laura Braden on Tue, Jan 12, 2016

Multiple myeloma is a rare form of cancer that affects the immune system in about 0.7% of Americans. According to the American Cancer Society, approximately 26,850 new cases were expected to be diagnosed in 2015, and 11,240 deaths were expected to occur. Although there are treatments available to fight this cancer, patients frequently relapse, demonstrating the need for new treatments.

Read More

Tags: Washington University St. Louis, Midwest, WashU, St. Louis Bioresearch Product Faire Event, cancer research, Cancer Treatment, MO, St Louis, new funding, 2016, BioResearch Product Faire, Multiple Myeloma

Emory Researchers Find Anti-Cancer Potential in Lichens and Rhubarb

Posted by Laura Braden on Mon, Nov 30, 2015

Cancer affects the majority of the population in one way or another, through knowing someone with cancer, being exposed to it in the media, or having it oneself. Cancer treatments and cures are some of the most well funded and highly researched areas in the life sciences. Researchers at the Winshop Cancer Institute at Emory University in Atlanta, GA recently discovered that an orange pigment, called parietin or physcion, that is found in lichens and rhubarb has potential to be used as an anti-cancer drug.

Read More

Tags: Emory University, Leukemia, cancer research, Southern, Cancer Treatment, Emory, BioResearch Product Faire Event, Atlanta, GA, Southern Region, 2016, Parietin, physcion

WSU Partners to Offer Genetic Cancer Screenings

Posted by Robert Larkin on Tue, Sep 29, 2015

Washington State University, in collaboration with a genetics testing company in India, is providing cancer patients with comprehensive testing for determining effective prostate and breast cancer treatments.

Read More

Tags: Washington, WSU Pullman, Microbiology, WA, cancer research, WSU, Washington State University, Cancer Treatment, pharmaceutical, 2015, Biomarkers, Genetics, Northwest Region, Pullman, BioResearch Product Faire™

UCLA Researchers I.D. Tumor-Fueling Mechanism

Posted by Robert Larkin on Tue, Aug 04, 2015

Like any living organism, cancer cells rely on fuel in order to survive and grow. Unfortunately for many, the growth of cancer cells is extremely deleterious to human health. That is why a major facet of cancer research currently involves locating and preventing the mechanism for fueling cancer cells.

Read More

Tags: CA, University of California Los Angeles, cancer research, California, Los Angeles, Cancer Treatment, 2015, LAVS, UCLA, Research Funding, Life Science, Biotechnology Vendor Showcase, Southwest Region, Prostate cancer

UCSD Gathers $7.6M for Ovarian Cancer Research

Posted by Robert Larkin on Tue, Jun 09, 2015

According to the National Cancer Institute (NCI), ovarian cancer accounts for approximately 3 percent of all cancers in women and is the fifth leading cause of cancer-related death among women in the United States. Ovarian cancer causes more deaths than any other female reproductive system cancer, due in part to a lack of symptoms during early stages and a lack of effective screening tests. In 2014, for example, an estimated 22,000 women were diagnosed with ovarian cancer in the United States, and approximately 14,000 died of the disease.

Read More

Tags: CA, University of California San Diego, cancer research, California, Cancer Treatment, Cancer, 2015, San Diego, SDVS, UCSD, Research Funding, UC San Diego, Biotechnology Vendor Showcase, NIH grants, ovarian cancer

Fred Hutchinson Researches Risk Reduction of Esophageal Cancer

Posted by Jennifer Nieuwkerk on Mon, Jul 01, 2013

A new study by science researchers at Fred Hutchinson Cancer Research Center found that a number of lifestyle changes may be able to reduce the risk of or manage esophageal cancer. People who don’t smoke, keep their weight down, get regular exercise, eat a diet rich in fruits and vegetables, don’t eat four hours before they go to sleep, and avoid foods and beverages that give you heartburn (including caffeine, alcohol, chocolate, peppermint, onions, green peppers and foods that are high in fat) have a greatly reduced risk of getting esophageal cancer. Another Fred Hutchinson study found that cholesterol-reducing drugs are also associated with reduced risk.

Read More

Tags: 2014, 2013, Fred Hutchinson Cancer Research Center, Washington, Medical Research, WA, Northwest, cancer research, WA research, Washington Life Science, Cancer Treatment, BioResearch Product Faire Event, Seattle, research science information, Hutch, Cancer Center

Bio Research Win: Supreme Court Rules Against Gene Patenting

Posted by Jaimee Saliba on Fri, Jun 14, 2013

In what is being hailed as a victory for both scientific research and patients' rights, the Supreme Court ruled unanimously yesterday that human genetic material cannot be patented. The case, Association for Molecular Pathology v. Myriad Genetics, has been working its way through the court system for a number of years now, led by plaintiffs including the ACLU, the American College of Medical Genetics, the American Society for Clinical Pathology, and numerous prominent genetic research scientists. The verdict invalidates the patents Myriad Genetics has held on breast cancer genes BRCA1 and BRCA2 since the 1990's and allows other labs besides theirs to test for mutations in those genes which, when present, strongly indicate a genetic predisposition to cancer. It also means that scientists can move forward in their genetic research without threat of being sued for copyright infringement. While the case was brought against Myriad specifically, the decision to disallow human gene patenting has profound implications for both scientific discovery and individual rights of ownership over our own genetic material.

Read More

Tags: 2014, CA, 2013, Bioresearch, gene patenting, cancer research, Southwest, Southwest life science marketing events, Cancer Treatment, San Diego, SDVS, Genetics, UC San Diego, biotech industry, Biotechnology Vendor Showcase

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!